The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Cancer Survival Complicates Chronic Pain Management
As long-term cancer survival rates continue to surge, an increasing percentage of patients with cancer-related pain are progressing to the chronic pain arena, which necessitates more contemporary treatment approaches to cancer pain management.
Pain Experts Poke Holes in Published Clinical Treatment Guidelines
Although they have all participated in the development of treatment guidelines for a variety of pain conditions, 3 comprehensive pain experts openly acknowledged and discussed the practical limitations of published evidence-based recommendations during the closing session of the American Academy of Pain Medicine 2014 Annual Meeting.
With Behavioral Support in Place, Opioid Dose Reduction Does Not Exacerbate Pain or Function
Reducing high-dose opioid therapy does not worsen pain severity, functional ability, or aberrant drug-related behaviors in chronic pain patients when concurrent biopsychosocial services are offered.
Predicting Positive and Negative Symptom Exaggeration in Chronic Pain Patients
Sometimes, chronic pain patients intentionally magnify or downplay their physical and mental symptoms during office visits. Despite that fact, little attention in the clinical setting is paid to underlying motives for positively or negatively biased self-reports.
Researchers Emphasize Routine Urine Drug Testing to Ensure Opioid Compliance, Enhance Pain Care
In light of the fact that many physicians continue to rely on observational analysis and patient self-reporting to monitor opioid addiction or misuse, results from a scientific poster reinforced the benefits of routine urine drug testing in improving compliance with prescribed opioid medications and ultimately enhancing pain care.
Guidelines for Knee Osteoarthritis Management Miss Treatment Targets
Though different sets of treatment recommendations for knee osteoarthritis send conflicting messages to practicing physicians, James W. Atchison, DO, pointed out that the guidelines focus solely on the knee, while pain management specialists focus on the whole person.
Osteoporosis Criteria Expanded to Include Fracture Risk
March 7th 2014An expert working group says osteoporosis can be diagnosed in postmenopausal women and older men with only marginally low bone density, if they have fractured certain bones in a minor mishap, show vertebral fractures on X-ray, or have high fracture risk for other reasons.
Finding Red Flags for Spinal Fracture, Malignancy in Low Back Pain
March 6th 2014Older age, chronic corticosteroid use, severe trauma, abrasion, or some combination of red flags predict an increased risk of spinal fracture, but a prior history of malignancy is the only useful predictor of spinal malignancy.
Anti-TNF Drugs Boost Quality of Life in Inflammatory Arthritis
March 4th 2014Tumor necrosis factor (TNF) blockers not only lower inflammation but also boost quality of life for patients with inflammatory arthritis, according to one of the largest comparative studies to date involving this class of drugs.
Osteoporosis Treatment May Be Useful in Brittle Bone Disease
February 26th 2014Although few treatment options are currently available for adult patients with brittle bone disease, a recent study found an anabolic treatment for osteoporosis also increases hip and spine bone mineral density in osteogenesis imperfecta patients, especially those with a milder form of the disorder.
The Riddle of Cardiovascular Disease in RA
February 25th 2014Cardiovascular risk is known to be increased among patients with rheumatoid arthritis (RA), but the interplay between inflammatory and cardiovascular causes and the possible role of medications muddle the picture. No wonder, perhaps, that rheumatologists have difficulty managing this risk. Here, some guidance from experts on the question.
Another IL-6 Receptor Blocker Disappoints in AS Trial
February 20th 2014For the second time, an interleukin-6 receptor-α inhibitor has proven no better than placebo against ankylosing spondylitis in a randomized trial. The highest dose of sarilumab was most effective, but not effective enough to pass muster.
Tracking the Trickster, Or: The Confounding Tale of IgG4-RD (Chapter III)
February 19th 2014Congratulations! In our last installment, despite the odds, you (presumably) reached the correct verdict: The villain responsible for your patient's misery is indeed IgG4-related disease, not one of the many other suspects. Now, what's the sentence?
RN Poll: Your Non-Drug Management of Knee OA
February 19th 2014With no "magic bullet" for knee osteoarthritis (OA), few good randomized trials for guidance about non-pharmacological management, and conflicting expert consensus about options such as hyaluronic acid injections, physicians are left to their own judgment about this exceedingly common rheumatic condition. What's your preferred advice for patients with new-onset knee OA? Answer our poll, and check your choices against those of your peers.
Rehabilitation Settings for Hip Fracture Repair in Veterans
February 19th 2014Since clinicians at US Department of Veterans Affairs hospitals are concerned that their hip fracture patients will not return to their preoperative functional levels, many wonder if particular types of rehabilitation can improve postoperative outcomes.